Article
The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein.
Journal of neurochemistry - 1 Dec 1999
Petanceska S S, Gandy S
Abstract excerpt
One of the hallmarks of Alzheimer's disease is the accumulation of senile plaques in brain, extracellular lesions comprised mostly of aggregates of the amyloid beta-peptide (Abeta). Abeta is proteolytically derived from the Alzheimer's amyloid precursor protein (APP). The generation of Abeta and nonamyloidogenic derivatives of APP involves utilization of alternative processing pathways and multiple subcellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
